Literature DB >> 25486875

Disturbed mitochondrial dynamics and neurodegenerative disorders.

Florence Burté1, Valerio Carelli2, Patrick F Chinnery1, Patrick Yu-Wai-Man1.   

Abstract

Mitochondria form a highly interconnected tubular network throughout the cell via a dynamic process, with mitochondrial segments fusing and breaking apart continuously. Strong evidence has emerged to implicate disturbed mitochondrial fusion and fission as central pathological components underpinning a number of childhood and adult-onset neurodegenerative disorders. Several proteins that regulate the morphology of the mitochondrial network have been identified, the most widely studied of which are optic atrophy 1 and mitofusin 2. Pathogenic mutations that disrupt these two pro-fusion proteins cause autosomal dominant optic atrophy and axonal Charcot-Marie-Tooth disease type 2A, respectively. These disorders predominantly affect specialized neurons that require precise shuttling of mitochondria over long axonal distances. Considerable insight has also been gained by carefully dissecting the deleterious consequences of imbalances in mitochondrial fusion and fission on respiratory chain function, mitochondrial quality control (mitophagy), and programmed cell death. Interestingly, these cellular processes are also implicated in more-common complex neurodegenerative disorders, such as Alzheimer disease and Parkinson disease, indicating a common pathological thread and a close relationship with mitochondrial structure, function and localization. Understanding how these fundamental processes become disrupted will prove crucial to the development of therapies for the growing number of neurodegenerative disorders linked to disturbed mitochondrial dynamics.

Entities:  

Mesh:

Year:  2014        PMID: 25486875     DOI: 10.1038/nrneurol.2014.228

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  227 in total

1.  A lethal defect of mitochondrial and peroxisomal fission.

Authors:  Hans R Waterham; Janet Koster; Carlo W T van Roermund; Petra A W Mooyer; Ronald J A Wanders; James V Leonard
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

Review 2.  OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape.

Authors:  Massimo Zeviani
Journal:  Brain       Date:  2008-02       Impact factor: 13.501

3.  155th ENMC workshop: polymerase gamma and disorders of mitochondrial DNA synthesis, 21-23 September 2007, Naarden, The Netherlands.

Authors:  Patrick F Chinnery; Massimo Zeviani
Journal:  Neuromuscul Disord       Date:  2007-12-21       Impact factor: 4.296

4.  Sensorineural hearing loss in OPA1-linked disorders.

Authors:  Stéphanie Leruez; Dan Milea; Sabine Defoort-Dhellemmes; Estelle Colin; Martine Crochet; Vincent Procaccio; Marc Ferré; Julie Lamblin; Valérie Drouin; Catherine Vincent-Delorme; Guy Lenaers; Christian Hamel; Catherine Blanchet; Gitte Juul; Michael Larsen; Christophe Verny; Pascal Reynier; Patrizia Amati-Bonneau; Dominique Bonneau
Journal:  Brain       Date:  2013-02-04       Impact factor: 13.501

5.  Regulation of mitochondrial morphology through proteolytic cleavage of OPA1.

Authors:  Naotada Ishihara; Yuu Fujita; Toshihiko Oka; Katsuyoshi Mihara
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

6.  Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.

Authors:  Raffaele Lodi; Caterina Tonon; Maria Lucia Valentino; David Manners; Claudia Testa; Emil Malucelli; Chiara La Morgia; Piero Barboni; Michele Carbonelli; Simone Schimpf; Bernd Wissinger; Massimo Zeviani; Agostino Baruzzi; Rocco Liguori; Bruno Barbiroli; Valerio Carelli
Journal:  Arch Neurol       Date:  2010-09-13

7.  The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.

Authors:  Emmanuelle Sarzi; Claire Angebault; Marie Seveno; Naïg Gueguen; Benjamin Chaix; Guy Bielicki; Nathalie Boddaert; Anne-Laure Mausset-Bonnefont; Chantal Cazevieille; Valérie Rigau; Jean-Pierre Renou; Jing Wang; Cécile Delettre; Philippe Brabet; Jean-Luc Puel; Christian P Hamel; Pascal Reynier; Guy Lenaers
Journal:  Brain       Date:  2012-12       Impact factor: 13.501

8.  Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells.

Authors:  Hidenori Otera; Chunxin Wang; Megan M Cleland; Kiyoko Setoguchi; Sadaki Yokota; Richard J Youle; Katsuyoshi Mihara
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

9.  Universal heteroplasmy of human mitochondrial DNA.

Authors:  Brendan A I Payne; Ian J Wilson; Patrick Yu-Wai-Man; Jonathan Coxhead; David Deehan; Rita Horvath; Robert W Taylor; David C Samuels; Mauro Santibanez-Koref; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2012-10-16       Impact factor: 6.150

10.  Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance.

Authors:  Gerald Pfeffer; Gráinne S Gorman; Helen Griffin; Marzena Kurzawa-Akanbi; Emma L Blakely; Ian Wilson; Kamil Sitarz; David Moore; Julie L Murphy; Charlotte L Alston; Angela Pyle; Jon Coxhead; Brendan Payne; George H Gorrie; Cheryl Longman; Marios Hadjivassiliou; John McConville; David Dick; Ibrahim Imam; David Hilton; Fiona Norwood; Mark R Baker; Stephan R Jaiser; Patrick Yu-Wai-Man; Michael Farrell; Allan McCarthy; Timothy Lynch; Robert McFarland; Andrew M Schaefer; Douglass M Turnbull; Rita Horvath; Robert W Taylor; Patrick F Chinnery
Journal:  Brain       Date:  2014-04-10       Impact factor: 13.501

View more
  235 in total

1.  Altered Mitochondrial Dynamics Contributes to Propofol-induced Cell Death in Human Stem Cell-derived Neurons.

Authors:  Danielle M Twaroski; Yasheng Yan; Ivan Zaja; Eric Clark; Zeljko J Bosnjak; Xiaowen Bai
Journal:  Anesthesiology       Date:  2015-11       Impact factor: 7.892

2.  Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L.

Authors:  Qilong Wang; Shengnan Wu; Huaiping Zhu; Ye Ding; Xiaoyan Dai; Changhan Ouyang; Young-Min Han; Zhonglin Xie; Ming-Hui Zou
Journal:  Autophagy       Date:  2017-01-13       Impact factor: 16.016

3.  Lysosomal Regulation of Inter-mitochondrial Contact Fate and Motility in Charcot-Marie-Tooth Type 2.

Authors:  Yvette C Wong; Wesley Peng; Dimitri Krainc
Journal:  Dev Cell       Date:  2019-06-20       Impact factor: 12.270

Review 4.  Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms.

Authors:  Jesse S Kerr; Bryan A Adriaanse; Nigel H Greig; Mark P Mattson; M Zameel Cader; Vilhelm A Bohr; Evandro F Fang
Journal:  Trends Neurosci       Date:  2017-02-09       Impact factor: 13.837

Review 5.  The Potential Application of Mitochondrial Medicine in Toxicologic Poisoning.

Authors:  David H Jang; Joshua W Lampe; Lance B Becker
Journal:  J Med Toxicol       Date:  2015-06

Review 6.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

Review 7.  Disease-Associated Genetic Variation in Human Mitochondrial Protein Import.

Authors:  Emmanuelle Nicolas; Rossella Tricarico; Michelle Savage; Erica A Golemis; Michael J Hall
Journal:  Am J Hum Genet       Date:  2019-05-02       Impact factor: 11.025

8.  Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias.

Authors:  Kyle Denton; Yongchao Mou; Chong-Chong Xu; Dhruvi Shah; Jaerak Chang; Craig Blackstone; Xue-Jun Li
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

9.  A validated active contour method driven by parabolic arc model for detection and segmentation of mitochondria.

Authors:  Serdar F Tasel; Erkan U Mumcuoglu; Reza Z Hassanpour; Guy Perkins
Journal:  J Struct Biol       Date:  2016-03-05       Impact factor: 2.867

Review 10.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.